Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+65.0%
5Y CAGR+27.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+65.0%/yr
vs -11.5%/yr prior
5Y CAGR
+27.3%/yr
Recent acceleration
Acceleration
+76.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $46.82M | +214.9% |
| 2024 | $14.87M | +16.1% |
| 2023 | $12.81M | +22.8% |
| 2022 | $10.43M | -50.8% |
| 2021 | $21.18M | +51.3% |
| 2020 | $14.00M | +289.2% |
| 2019 | $3.60M | -78.8% |
| 2018 | $17.00M | +256.9% |
| 2017 | $4.76M | -3.4% |
| 2016 | $4.93M | - |